Recent Advances in Blood Coagulation

Progress in clinical fibronolysis; platelets; molecular markers of in vivo coagulation and thrombosis; factory V III; lupus anticoagulants; tissue factor pathway inhibitor; antiplatelet agents - pharmacology and clinical use; thrombosis in infancy and risks of maternal thrombosis to the infant; problems of international normalized ratio implementation in prothrombin time standardization; an overview of non-heparin glycosaminoglycans as antithrombotic agents; reviews of some key papers published in 1991/1992.